Functional interaction between fluorodeoxyuridine-induced cellular alterations and replication of a ribonucleotide reductase-negative herpes simplex virus

Journal of Virology

Volumn 75, Issue 15, 2001, Pages 7050-7058

  Petrowsky, H ^a   Roberts, G D ^a   Kooby, D A ^a   Burt, B M ^a   Bennett, J J ^a   Delman, K A ^a   Stanziale, S F ^a   Delohery, T M ^a   Tong, W P ^a   Federoff, H J ^a   Fong, Y ^a  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FLOXURIDINE; HYDROXYUREA; RIBONUCLEOTIDE REDUCTASE;

ARTICLE; CONTROLLED STUDY; CYTOTOXICITY; HERPES SIMPLEX VIRUS; HUMAN; HUMAN CELL; NONHUMAN; PRIORITY JOURNAL; VIROGENESIS; VIRUS ACTIVATION; VIRUS ATTENUATION; VIRUS CELL INTERACTION; VIRUS INHIBITION; VIRUS MUTANT; VIRUS REPLICATION;

EID: 0034947844     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/JVI.75.15.7050-7058.2001     Document Type: Article

References (43)

1. Novel mechanism(s) of resistance to 5-fluorouracil in human colon cancer (HCT8) sublines following exposure to two different clinically relevant dose schedules
2. Ribonucleotide reductase induced by herpes simplex type-1 virus
3. Accumulation of DNA strand breaks during thymineless death in thymidylate synthetase-negative mutants of mouse FM3A cells
4. S-phase-specific expression of mammalian ribonucleotide reductase R1 and R2 subunit mRNAs
5. Herpes simplex virus DNA replication
6. Controlled protein degradation regulates ribonucleotide reductase activity in proliferating mammalian cells during the normal cell cycle and in response to DNA damage and replication blocks
7. 134.5 protein of herpes simplex virus type 1 is required for the formation of a high-molecular-weight complex that dephosphorylates eIF-2α
8. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction
9. 134.5 gene function, which blocks the host response to infection, maps in the homologous domain of the genes expressed during growth arrest and DNA damage
10. 134.5, a gene nonessential for growth in culture
11. 134.5-mutants of herpes simplex virus 1
12. Nucleoside 5′-diphosphates as effectors of mammalian ribonucleotide reductase
13. Thymidylate synthetase-substrate complex formation
14. The incorporation of 5-fluoro-2′-deoxyuridine into DNA of mammalian tumor cells
15. Time-dependent changes in H1 content, H1 turnover, DNA elongation, and the survival of cells blocked in early S phase by hydroxyurea, aphidicolin, or 5-fluorodeoxyuridine
16. Ribonucleotide reductase and cell proliferation. I. Variations of ribonucleotide reductase activity with tumor growth rate in a series of rat hepatomas
17. Cell cycle-dependent expression of mammalian ribonucleotide reductase
18. Localization of ribonucleotide reductase in mammalian cells
19. Role of a proximal NF-Y binding promoter element in S phase-specific expression of mouse ribonucleotide reductase R2
20. Factor(s) present in herpes simplex virus type 1-infected cells can compensate for the loss of the large subunit of the viral ribonucleotide reductase: Characterization of an ICP6 deletion mutant
21. Herpes simplex virus type 1-induced ribonucleotide reductase activity is dispensable for virus growth and DNA synthesis: Isolation and characterization of an ICP6 lacZ insertion mutant
22. Mechanism of thymineless death
23. Characterization of the free radical of mammalian ribonucleotide reductase
24. 134.5 protein of herpes simplex virus 1 complexes with protein phosphatase 1alpha to dephosphorylate the alpha subunit of the eukaryotic translation initiation factor 2 and preclude the shutoff of protein synthesis by double-stranded RNA-activated protein kinase
25. Mammalian GADD34, an apoptosis- and DNA damage-inducible gene
26. DNA fragmentation and cytotoxicity from increased cellular deoxyuridylate
27. The regulation of thymidylate biosynthesis in Novikoff hepatoma cells and the effects of amethopterin, 5-fluorodeoxyuridine, and 3-deazauridine
28. Oncolytic viral therapy for human colorectal cancer and liver metastases using a multi-mutated herpes simplex virus type-1 (G207)
29. Conditionally replicating herpes simplex virus mutant, G207 for the treatment of malignant glioma: Results of a phase I trial
30. Neurovirulence factor
31. Attenuated multi-mutated herpes simplex virus-1 for the treatment of malignant gliomas
32. Flow cytometric analysis of G1- and G2/M-phase subpopulations in mammalian cell nuclei using side scatter and DNA content measurements
33. Protein phosphorylation in translational control
34. PKR: A new name and new roles
35. Herpes simplex virus and their replication
36. NMR studies of binding of 5-FdUDP and dCDP to ribonucleoside-diphosphate reductase from Escherichia coli
37. The eIF-2 alpha protein kinases, regulators of translation in eukaryotes from yeast to humans
38. A rapid assay for CDP reductase activity in mammalian cell extracts
39. A ribonucleotide reductase gene involved in a p53-dependent cell-cycle checkpoint for DNA damage
40. Reduction of ribonucleotides
41. 134.5 deletion mutants in rodent models
42. Deoxyribonucleoside triphosphate imbalance. 5-fluorodeoxyuridine-induced DNA double strand breaks in mouse FM3A cells and the mechanism of cell death
43. The gadd and MyD genes define a novel set of mammalian genes encoding acidic proteins that synergistically suppress cell growth